DYVELIA PHARMA SL
Company details
- No Activa NIF/CIF: B87577615
-
-
-
-
Address: Vía de las Dos Castillas, 9C, 28224 Pozuelo de Alarcón, Madrid, España See in map
-
-
Featured products:
More information on DYVELIA PHARMA SL
-
VELASCO IBAÑEZ ANTONIOAdministrador solidarioTermination of employment: 08/08/2019
-
VICENS PARRA FERNANDOAdministrador solidarioTermination of employment: 08/08/2019
-
CREDI APREA GILBERT-NADERAdministrador solidarioTermination of employment: 08/08/2019
-
CREDI APREA GILBERT-NADERLiquidadorAppointment: 08/08/2019
-
08/08/2019 | BORME act no.: 348357 | Register: MADRIDCeses/Dimisiones
-
08/08/2019 | BORME act no.: 348357 | Register: MADRIDNombramientos
-
08/08/2019 | BORME act no.: 348357 | Register: MADRIDDisolución
-
21/06/2016 | BORME act no.: 261093 | Register: MADRIDConstitución
-
21/06/2016 | BORME act no.: 261093 | Register: MADRIDNombramientos
Other information
The CIF assigned to DYVELIA PHARMA SL is B87577615, and its commercial status is dissolved. The company carries out its operations within the CNAE 4646 - Comercio al por mayor de productos farmacéuticos. Likewise, its SIC code - identifies it.
DYVELIA PHARMA SL employs a team of Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The entity is registered in the Mercantile Registry of Madrid and has 4 registration charges. The last announcement in Borme was published on 08/08/2019, while the most recent deposit of ordinary annual accounts is from the year -.
To access the contact information of DYVELIA PHARMA SL, such as the phone number, address, or website, visit the Company Data module.
If you require additional information about DYVELIA PHARMA SL, you can review one of our available financial reports, the Annual Accounts of the company, or verify its default incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about DYVELIA PHARMA SL comes from official sources and is regularly updated.
Do you want to know more about DYVELIA PHARMA SL??
Find out more about this company by consulting these reports: